Supporting information S-3 Figure S1. Conformational search of tolane4-PNA/DNA duplex. The PNA/DNA duplex structures were obtained as 1PDT from the PDB data bank. Gray; tolane4, Green; PNA backbone, Purple; DNA backbone, Orange; PNA8. Left: Tolane interacted to the adjacent PNA/DNA base pair and
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Methyl 2-(4-bromophenyl)acetate (2a) (2.0 g, 8.73 mmol) was dissolved in 14 mL of N, N, N', N'tetramethylethylendiamine (TMEDA) and 1.5 ml of H2O. Disodium tetrachloropalladate (Na2PdCl4, 23mg, 0.08 mmol), Copper (I) iodide (30 mg, 0.16 mmol), 2-(di-tert-butylphosphino)-N-phenylindole (PIntB, 62 mg, 0.16 mmol), ethynylbenzene (0.87 mL, 7.94 mmol) was added and the reaction was stirred at 80 °C under Ar until all the starting material was consumed as judged by TLC. Water was added to the solution then extracted three times with ethyl acetate. The organic phase was washed two times with saturated ammonium chloride, brine and then dried over magnesium sulfate. The solvent was evaporated and the residue was purified by column chromatography (hexane : ethyl acetate=4:1(v/v)) to yield the product (1.40 g, 64%).; 1 
2-(4-(Phenylethynyl)phenyl)acetic acid (2) [1]
2-(4-(Phenylethynyl)phenyl)acetate (2b) (1.40 g, 5.58 mmol) was dissolved in 25ml of THF, and lithium hydroxide monohydrate (470 mg, 11.2 mmol) dissolved in 10 ml of H2O was added to the solution and stirred at room temperature until all the starting material was consumed, as was monitored by TLC. Water was added to the solution and the pH was adjusted to pH < 1 with 3% HCl solution. The solution was extracted three times with ethyl acetate, washed with brine, and then dried over magnesium sulfate. The solvent was evaporated under reduced pressure to yield the product 1 ( 
Methyl 4-(4-(phenylethynyl)phenyl)butanoate (3b) [1]
Methyl 4-(4-bromophenyl)butanoate (3a) (1.0 g, 3.89 mmol) was dissolved in 6 ml of N, N, N', N'tetramethylethylendiamine (TMEDA) and 
4-(4-(phenylethynyl)phenyl)butanoic acid (3) [1]
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Methyl 4-(4-(phenylethynyl)phenyl)butanoate (3b) ( 
5-(4-Iodophenyl)pentanoic acid (4a)
5-Phenylpentanoic acid (1.0 g, 5.61 mmol), H5IO6 (260 mg, 1.12 mmol), I2 (280 mg, 2.24 mmol), 2 ml of 10 M H2SO4, 6ml of glacial acetic acid, 1.2 ml of H2O were stirred at 75 °C under Ar for 18 hours. After the mixture was cooled to room temperature, water was added to the solution. The aqueous phase was washed three times with chloroform and the combined organic layers were washed two times with sodium thiosulfate, brine and dried over magnesium sulfate. The solvent was evaporated under reduced pressure and a small amount of chloroform was added. The product was recrystallized from hexane (405mg, 24%); 1 H-NMR (400 MHz, CDCl3, ): 7.59 (d, 2H), 6.93 (d, 2H), 2.59 (t, 2H), 2.38 (t, 2H), 1.65(q, 4H).
Methyl 5-(4-iodophenyl)pentanoate (4b)
Acetyl chloride (0.3 mL, 4.00 mmol) was dropped into 5 ml of methanol at 0 °C and stirred for Supporting information S-10 ten minutes under Ar. 5-(4-iodophenyl)pentanoic acid (4a) (405 mg, 1.33 mmol) was added to the solution, and stirred at room temperature for two hours. The solution was neutralized with potassium carbonate and evaporated under reduced pressure. The residue was dissolved in ethyl acetate, washed with water and brine, and the organic layer was dried over magnesium sulfate.
The solvent was evaporated under reduced pressure to yield the product (445 mg, quant) and used to next step without further purification; 1 
5-(4-(Phenylethynyl)phenyl)pentanoic acid (4)
Methyl 5-(4-(phenylethynyl)phenyl)pentanoate (4c) (395 mg, 1.35 mmol) was dissolved in 7 mL of THF, and lithium hydroxide monohydrate (113 mg, 2.70 mmol) dissolved in 3 ml of H2O was added to the solution and stirred at room temperature until all the starting material was consumed, as 
6-(4-(Phenylethynyl)phenyl)hexanoic acid (5)
Product 5 was synthesized from 6-phenylhexanoic acid (1.0g, 5.20 mmol) employing the same procedure used for product 4. However, its iodo-derivative at the first step could not be recrystallized because of its oily nature. Therefore, crude products was used in each step and finally, the crude product at the last step was recrystallized from hexane-chloroform to yield product 5 (226mg, 15% over 4 steps); 1 
Ethyl 2-(4-bromophenethoxy)acetate (6a)
Sodium hydride (60% in mineral oil 220 mg, 5.47 mmol)) was suspended in 15 ml of THF at 
2-(4-(Phenylethynyl)phenethoxy)acetic acid (6)
Ethyl 
Methyl 3-((4-(phenylethynyl)benzyl)oxy)propanoate (7b)
3-((4-(Phenylethynyl)benzyl)oxy)propanoic acid (7)
S-14
Methyl 3-((4-(phenylethynyl)benzyl)oxy)propanoate (7b) (978 mg, 3.32 mmol) was dissolved in 15 mL of THF, and lithium hydroxide monohydrate (280 mg, 6.65 mmol) dissolved in 7 ml of H2O was added to the solution and stirred at room temperature until all the starting material was 
2-(4-(Naphthalen-2-ylethynyl)phenethoxy)acetic acid (9)
S-15
Ethyl 2-(4-(naphthalen-2-ylethynyl)phenethoxy)acetate (9a) (72 mg, 0.20 mmol) was dissolved in 1.5 mL of THF, and lithium hydroxide monohydrate (17 mg, 0.40 mmol) dissolved in 0.5 ml H2O
was added to the solution and stirred at room temperature until all the starting material was consumed, as was monitored by TLC. Water was added to the solution and the pH was adjusted to 
2-(4-(Pyren-1-ylethynyl)phenethoxy)acetic acid (10)
S-16
Ethyl 2-(4-(pyren-1-ylethynyl)phenethoxy)acetate (10a) (70 mg, 0.16 mmol) was dissolved in 
2-(4-((4-Methoxyphenyl)ethynyl)phenethoxy)acetic acid (11)
S-17
Ethyl 2-(4-((4-methoxyphenyl)ethynyl)phenethoxy) acetate (11a) (35 mg, 0.10 mmol) was dissolved in 1.0 mL of THF, and lithium hydroxide monohydrate (9 mg, 0.21 mmol) dissolved in 0.5 ml of H2O was added to the solution and stirred at room temperature until all the starting material was consumed, as was monitored by TLC. Water was added to the solution and the pH was adjusted to pH < 1 with 3% HCl solution. The combined organic layers were extracted three times with ethyl acetate, washed with brine, and then dried over magnesium sulfate. The solvent was evaporated under reduced pressure to yield the product 11 (31 mg, 97%); 1 
Ethyl 2-(4-((4-cyanophenyl)ethynyl)phenethoxy)acetate (12a)
Ethyl 2-(4-bromophenethoxy) acetate (112 mg, 0.39 mmol) was dissolved in 2 mL of N, N, N', N'tetramethylethylendiamine (TMEDA) and 0.5 ml of H2O. Disodium tetrachloropalladate (Na2PdCl4, 1.1 mg, 3.90 umol), Copper (I) iodide (1.5 mg, 7.80 umol), 2-(di-tert-butylphosphino)-N-phenylindole (PIntB, 3.11 mg, 7.80 umol), 4-Ethynylbenonitrile (149 mg, 1.17 mmol) was added and the reaction was stirred at 80 °C under Ar until all starting material was consumed, as was monitored by TLC. Water was added to the solution then extracted three times with ethyl acetate. The combined organic layers were washed two times with saturated ammonium chloride, brine and then dried over magnesium sulfate. The solvent was evaporated under reduced pressure and the residue was purified by column chromatography (hexane : ethyl acetate=8:1(v/v)) to yield the product (37 mg, 29%); 1 H-NMR (400 MHz, CDCl3,
